retatrutide 16 mg Promises Big Weight Loss, but Safety Remains a Question Retatrutide: The New Triple-Agonist Weight

Wegovy Prescribing Information, revised February 2026

Learn More About Retatrutide What is Retatrutide Retatrutide is a first-in-class synthetic peptide developed by Eli Lilly that simultaneously activates three hormone receptors glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon that together govern appetite, metabolism, insulin sensitivity, energy expenditure, and fat oxidation

[28] Vitamin B 12 additionally becomes inactive when exposed to intense heat or electromagnetic radiation

Good vascular function plays a big role in overall healing

Food environment still matters: GLP-1 drugs may reduce reward-driven eating, but they don't eliminate it entirely and they don't build the habits that sustain health after medication ends

2015 Apr;95(2):513-48